No Data
No Data
No Data
No Data
No Data
Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
Yahoo FinanceFeb 13 09:00 ET
Express News | Trading Halt: Halt Status Updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times
Moomoo 24/7Jan 25 09:00 ET
Revelation Biosciences Inc. Announces 1-for-30 Reverse Stock Split Effective January 25, 2024
Yahoo FinanceJan 23 09:00 ET
Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Recent Corporate Progress
Globe Newswire 15-Aug-2022 5:30 PMSAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that
Globe NewswireAug 15, 2022 17:35 ET
Revelation Biosciences Inc. Announces Closing of $5 Million Public Offering
SAN DIEGO, July 29, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on the development of
GlobeNewswireJul 29, 2022 11:50 ET
Revelation Biosciences stock slides 47% on pricing $5M securities offering
Revelation Biosciences (NASDAQ:REVB) shares dropped 47% pre-market on Tuesday after the life sciences company priced its $5M securities offering. The offering consists of 8.33M shares of common stock
Seeking AlphaJul 26, 2022 08:37 ET
No Data
No Data